This unique report provides information and analysis not available from any other published source.
Summary
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.
The report explores business and technological trends; provides specimen, sales and volume forecasts for 40 tests; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
Hematology Tests Analyzed in the Report
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests Analyzed in the Report
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Technology Review
- Assessment of current and emerging technologies, and their market applications.
Strategic Recommendations
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
